These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 10368043

  • 1. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
    Bachaud JM, Berthier F, Soulié M, Malavaud B, Plante P, Rischmann P, Chevreau C, Daly-Schveitzer N, Grosclaude P.
    Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
    [Abstract] [Full Text] [Related]

  • 2. [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
    Bachaud JM, Berthier F, Soulié M, Malavaud B, Plante P, Rischmann P, Chevreau C, Grosclaude P.
    Prog Urol; 1999 Sep; 9(4):689-95. PubMed ID: 10555222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB, Antoniolli SZ, Maffei N, Beltrami P, Bassetto MA, Curti P.
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
    Patterson H, Norman AR, Mitra SS, Nicholls J, Fisher C, Dearnaley DP, Horwich A, Mason MD, Huddart RA.
    Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
    [Abstract] [Full Text] [Related]

  • 7. Adverse effects after radiotherapy for early stage (I,IIa,IIb) seminoma.
    Majewski W, Majewski S, Maciejewski A, Kolosza Z, Tarnawski R.
    Radiother Oncol; 2005 Sep; 76(3):257-63. PubMed ID: 15921773
    [Abstract] [Full Text] [Related]

  • 8. Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.
    Souchon R, Hartmann M, Krege S, Lorch A, Mayer F, De Santis M, Gillessen S, Beyer J, Cathomas R.
    Strahlenther Onkol; 2011 Mar; 187(3):158-66. PubMed ID: 21347634
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy.
    Hallemeier CL, Davis BJ, Pisansky TM, Choo R.
    Urol Oncol; 2014 May; 32(4):496-500. PubMed ID: 24332645
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy.
    Glaser SM, Vargo JA, Balasubramani GK, Beriwal S.
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):513-21. PubMed ID: 27146264
    [Abstract] [Full Text] [Related]

  • 13. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
    Simone CB, Kramer K, O'Meara WP, Bekelman JE, Belard A, McDonough J, O'Connell J.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):242-9. PubMed ID: 21236595
    [Abstract] [Full Text] [Related]

  • 14. Management of stage II seminoma.
    Warde P, Gospodarowicz M, Panzarella T, Catton C, Sturgeon J, Moore M, Jewett M.
    J Clin Oncol; 1998 Jan 01; 16(1):290-4. PubMed ID: 9440755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
    Lewinshtein D, Gulati R, Nelson PS, Porter CR.
    BJU Int; 2012 Mar 01; 109(5):706-12. PubMed ID: 21883828
    [Abstract] [Full Text] [Related]

  • 18. Long-term results in patients affected by testicular seminoma treated with radiotherapy: risk of second malignancies.
    Fatigante L, Ducci F, Campoccia S, Nocita AM, Paci E, Crocetti E, Cionini L.
    Tumori; 2005 Mar 01; 91(2):144-50. PubMed ID: 15948542
    [Abstract] [Full Text] [Related]

  • 19. Risks of second malignancies after breast cancer treatment: Long-term results.
    Bazire L, De Rycke Y, Asselain B, Fourquet A, Kirova YM.
    Cancer Radiother; 2017 Feb 01; 21(1):10-15. PubMed ID: 28034681
    [Abstract] [Full Text] [Related]

  • 20. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB, Antoniolli SZ, Schiavone D, Maffei N, Bassetto MA, Curti P.
    Arch Ital Urol Androl; 2002 Jun 01; 74(2):77-80. PubMed ID: 12161941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.